![L. William McIntosh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
L. William McIntosh
Directeur Général chez
Q-RNA, Inc.
Profil
L.
William McIntosh is the founder of Treventis Corp.
Current job includes Chief Executive Officer at Q-RNA, Inc. Former jobs include President & Chief Executive Officer at Nexell Therapeutics, Inc., Director at VIRxSYS Corp., Director at Oligomerix, Inc., Director at Signature Capital LLC, Principal at Medco Containment Services, Inc., Principal at Merck & Co., Inc., Principal at Zynaxis, Inc., Principal at GSK Plc, Principal at VIMRx Pharmaceuticals, Inc., Chief Operating Officer at Woodbrook Group Holdings, Inc. in 2006, and Principal at Boehringer Mannheim Pharmaceuticals Corp.
and President & Chief Operating Officer at FASgen, Inc. Education includes undergraduate and MBA from Lehigh University.
Postes actifs de L. William McIntosh
| Sociétés | Poste | Début |
|---|---|---|
Q-RNA, Inc.
 Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of Alzheimer's disease | Directeur Général | - |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Fondateur | - |
Anciens postes connus de L. William McIntosh
| Sociétés | Poste | Fin |
|---|---|---|
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | President | 05/04/2010 |
| WOODBROOK GROUP HOLDINGS INC. | Directeur des opérations | 01/12/2006 |
Signature Capital LLC
 Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
VIMRx Pharmaceuticals, Inc.
 VIMRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Corporate Officer/Principal | - |
Formation de L. William McIntosh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Medco Containment Services, Inc.
 Medco Containment Services, Inc. Miscellaneous ManufacturingProducer Manufacturing Unsupported plastics profile shapes | Producer Manufacturing |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Nexell Therapeutics, Inc.
 Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical therapies | Health Technology |
Zynaxis, Inc.
 Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery systems | Commercial Services |
Q-RNA, Inc.
Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of Alzheimer's disease | Health Technology |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology Develops gene based therapies | Health Technology |
Oligomerix, Inc.
 Oligomerix, Inc. Drugstore ChainsRetail Trade Develops novel therapeutics and diagnostic assays for alzheimer diseases | Retail Trade |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
VIMRx Pharmaceuticals, Inc.
VIMRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Signature invests in early-stage growth technology companies in the following areas: electronic equipment/devices, application-specific semiconductor products, telecommunications, medical/biotechnology (healthcare products or therapies), Internet businesses and technology based service companies. They look for companies that have a proprietary position in timely new products or services and serve a large, established market that will allow rapid scalability of revenue to over $100 million per year. The company must strong, visionary managers and be in a field with good valuations in the securities markets | Finance |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Woodbrook Group Holdings, Inc.
 Woodbrook Group Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
Boehringer Mannheim Pharmaceuticals Corp. | |
FASgen, Inc.
 FASgen, Inc. Pharmaceuticals: MajorHealth Technology Develops novel molecule therapeutics | Health Technology |
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
